top of page

PIPELINE
We are currently evaluating the immunogenicity and efficacy of Hiltonol® (PICLC) alone, with vaccines or with immune costimulators over a variety of indications in Phase I and II clinical trials. (See clinicaltrials.gov for a complete list)
.png)
Hiltonol® Collaborative Clinical Trials by Indication (see clinicaltrials.gov for a complete list)
.png)
# of Phase I/II Clinical Trials
bottom of page